baxalta.fi
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome
540-8645 Chuo-Ku, Osaka
JP
540-8645 Chuo-Ku, Osaka
JP
Y-tunnus: 1200-01-077461
Puh:
Puh:
Lähde: Traficom
Siirry verkkotunnukseen
Verkkotunnus on ONLINE (ping: 113 ms)
Baxalta.fi on rekisteröity 10 vuotta sitten. Verkkotunnuksen haltija on Takeda Pharmaceutical Company Limited ja välittäjänä toimii CSC Corporate Domains, Inc..
Verkkotunnuksen rekisteröintitiedot
Rekisteröity:
24.09.2014
Päättyy:
24.09.2025
Vapautuu:
24.10.2025
Tila:
Registered
Välittäjä:
CSC Corporate Domains, Inc.
Palvelimen IP:
76.223.3.151
Nimipalvelimet:
ns-1041.awsdns-02.org
ns-1583.awsdns-05.co.uk
ns-396.awsdns-49.com
ns-701.awsdns-23.net
ns-1583.awsdns-05.co.uk
ns-396.awsdns-49.com
ns-701.awsdns-23.net
Haltijan muut verkkotunnukset (92)
Verkkotunnus
Rekisteröity:
SEO raportti
Otsikko
United States | Home
Kuvaus
Welcome to Takeda in the U.S. We’re the largest life sciences employer in the state of Massachusetts with our global hub and research center in Cambridge, MA., and have sites across the U.S. in 39 states
H1 Otsikot (1)
- United States | Home
H2 Otsikot (5)
- United States
- Our Stories
- Newsroom
- Careers
- Contact Us
H3 Otsikot (8)
- Takeda - U.S.
- Forging partnerships that improve community health
- Driving innovation for the life sciences ecosystem
- Developing the next generation of problem solvers
- Takeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand STEM Education
- Takeda Announces Approval of GLASSIA® (Alpha-1 Proteinase Inhibitor [Human]) 4- and 5-gram Vial Sizes
- COMMUNITY-DRIVEN, SUSTAINABLE DEVELOPMENT PROJECT AT 585 KENDALL REACHES MAJOR CONSTRUCTION MILESTONE
- Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
H4 Otsikot (0)
H5 Otsikot (0)
H6 Otsikot (0)